Mr Sinha has served as a Non-Executive Director on our board of directors since September 2016.
Mr Sinha has over 20 years of experience working in executive finance roles in the life sciences industry. He is Chief Financial Officer of Scholar Rock, a public biopharmaceutical company, and Co-founder of ElevateBio, a holding company focused on building cell and gene therapy companies. Mr Sinha served as President and CFO of AlloVir, an ElevateBio portfolio company, from September 2018 to March 2025. From 2005 to 2016, he was the CFO of Alexion Pharmaceuticals. Prior to joining Alexion, Mr Sinha held various positions with Bayer across the world including CFO, Bayer North America and CFO Bayer Yakuhin, Japan. Mr Sinha holds an MBA in business administration from the Asian Institute of Management. He is a qualified Chartered Accountant from the Institute of Chartered Accountants of India and a Certified Public Accountant in the US.
